AU2012245538B2 - Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents - Google Patents

Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents Download PDF

Info

Publication number
AU2012245538B2
AU2012245538B2 AU2012245538A AU2012245538A AU2012245538B2 AU 2012245538 B2 AU2012245538 B2 AU 2012245538B2 AU 2012245538 A AU2012245538 A AU 2012245538A AU 2012245538 A AU2012245538 A AU 2012245538A AU 2012245538 B2 AU2012245538 B2 AU 2012245538B2
Authority
AU
Australia
Prior art keywords
composition
viscosity
enhancing agent
viscosity enhancing
dissipation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2012245538A
Other languages
English (en)
Other versions
AU2012245538A1 (en
Inventor
Masood A. Chowhan
Malay Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Research LLC
Original Assignee
Alcon Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Research LLC filed Critical Alcon Research LLC
Publication of AU2012245538A1 publication Critical patent/AU2012245538A1/en
Application granted granted Critical
Publication of AU2012245538B2 publication Critical patent/AU2012245538B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2012245538A 2011-04-22 2012-04-19 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents Expired - Fee Related AU2012245538B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161478081P 2011-04-22 2011-04-22
US61/478,081 2011-04-22
PCT/US2012/034171 WO2012145460A2 (en) 2011-04-22 2012-04-19 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents

Publications (2)

Publication Number Publication Date
AU2012245538A1 AU2012245538A1 (en) 2013-10-17
AU2012245538B2 true AU2012245538B2 (en) 2017-06-15

Family

ID=46025951

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012245538A Expired - Fee Related AU2012245538B2 (en) 2011-04-22 2012-04-19 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents

Country Status (10)

Country Link
US (1) US20120269862A1 (cg-RX-API-DMAC7.html)
EP (1) EP2699228A2 (cg-RX-API-DMAC7.html)
JP (2) JP2014525891A (cg-RX-API-DMAC7.html)
KR (1) KR20140022900A (cg-RX-API-DMAC7.html)
CN (1) CN104039307A (cg-RX-API-DMAC7.html)
AU (1) AU2012245538B2 (cg-RX-API-DMAC7.html)
CA (1) CA2833591A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013012307A (cg-RX-API-DMAC7.html)
RU (1) RU2013152013A (cg-RX-API-DMAC7.html)
WO (1) WO2012145460A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10174006B2 (en) * 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
CN113366025A (zh) 2019-01-30 2021-09-07 鲍希与洛姆伯股份有限公司 交联的聚合物网络及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253280A1 (en) * 2003-06-13 2004-12-16 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CN101073556A (zh) * 2007-06-25 2007-11-21 苏州瑞桥医药科技有限公司 一种散瞳眼用制剂及其制备方法
US20100226997A1 (en) * 2009-03-05 2010-09-09 Lyle Bowman Controlled-release ophthalmic vehicles
CN101057966B (zh) * 2007-05-16 2011-04-13 中国科学院上海药物研究所 一种表皮生长因子眼用脂质纳米载体原位凝胶制剂

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
DE69818675T2 (de) 1997-07-29 2004-07-29 Alcon Laboratories, Inc., Fort Worth Galaktomannanpolymere und borat enthaltende augenarzneimittel
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
JP5000835B2 (ja) * 2000-08-25 2012-08-15 千寿製薬株式会社 水性懸濁液剤
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
JP4850513B2 (ja) * 2003-07-03 2012-01-11 株式会社メニコン 点眼用組成物
JP4963359B2 (ja) * 2005-01-12 2012-06-27 ロート製薬株式会社 眼局所適用製剤
AU2009225931B9 (en) 2008-03-17 2014-04-03 Novartis Ag Aqueous pharmaceutical compositions containing borate-polyol complexes
CN101564374A (zh) * 2008-04-25 2009-10-28 北京和润创新医药科技发展有限公司 一种药物眼用即型凝胶
JP5731980B2 (ja) * 2008-10-09 2015-06-10 ラムズコア, インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸-多元醇錯合物之水性藥學組成物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253280A1 (en) * 2003-06-13 2004-12-16 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CN101057966B (zh) * 2007-05-16 2011-04-13 中国科学院上海药物研究所 一种表皮生长因子眼用脂质纳米载体原位凝胶制剂
CN101073556A (zh) * 2007-06-25 2007-11-21 苏州瑞桥医药科技有限公司 一种散瞳眼用制剂及其制备方法
US20100226997A1 (en) * 2009-03-05 2010-09-09 Lyle Bowman Controlled-release ophthalmic vehicles

Also Published As

Publication number Publication date
RU2013152013A (ru) 2015-05-27
KR20140022900A (ko) 2014-02-25
EP2699228A2 (en) 2014-02-26
CN104039307A (zh) 2014-09-10
MX2013012307A (es) 2014-01-31
AU2012245538A1 (en) 2013-10-17
CA2833591A1 (en) 2012-10-26
WO2012145460A3 (en) 2014-07-24
WO2012145460A2 (en) 2012-10-26
JP2014525891A (ja) 2014-10-02
JP2017088629A (ja) 2017-05-25
US20120269862A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
AU2009322355B2 (en) Pharmaceutical suspension
JP5877885B2 (ja) 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム
AU2010200297B2 (en) Ophthalmic compositions containing a synergistic combination of two polymers
JP2012511009A5 (cg-RX-API-DMAC7.html)
JP2019142979A (ja) 水性液剤
JP2019142974A (ja) 水溶性高分子を含む水性液剤
JP2022190022A (ja) 水溶性高分子を含む点眼剤
KR20130100273A (ko) 점안용 수성 조성물
US20120270955A1 (en) Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
US9138481B2 (en) Cellulosic gel composition with improved viscosity stability
JP2017088629A (ja) 二つの異なる粘性増強剤を有する粘性増強システムを備えた眼科用組成物

Legal Events

Date Code Title Description
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee